No Data
No Data
Onconetix: Received Staff Delisting Letter From the Nasdaq Cap Market on April 24 >ONCO
Onconetix: Letter Indicated Failure to File Annual Report on Form 10-K for the Fiscal Yr Is in Violation of Nasdaq's Continued Listing Requirements >ONCO
Onconetix, Inc. Announces Receipt of Additional Notice From Nasdaq
Why Onconetix (ONCO) Stock Is Exploding Higher
Onconetix Signs Letter Of Intent Contemplating Business Combination With Ocuvex Therapeutics
Express News | Onconetix- Post Close, Pre-Closing Ocuvex Equity Holders Will Own About 90% of Equity Interests in Onconetix